Market Cap
$167.7M
FOCL
EDAP TMS SA
$4.20 ▼ -2.78%
Prev close $4.32Market cap$167.7M
ConsensusBuy
12-mo target$8.80 (+109.5%)
▲ Bullish
Analyst conviction 7/10
Insider Buying Cluster (4 insiders)High Impact Filing (7/10)3 New Institutional Positions
Snapshot
The big-picture read on FOCL right now — valuation, ownership and activity at a glance.
Cap Size
Micro Cap
Analyst Consensus
Strong Buy (73%)
Inst. Holders
21 funds
Inst. Value
$25.8M
Inst. Activity
3 buys / 1 sells
Insider Activity
$408.5K buy / $0.00 sell
Insider Net $
$408.5K
SEC Reports
5
Press Releases
1
Price chart 30d +0.7%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 1, 2026 other
Aug 19, 2026 SEC FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 202
EDAP TMS SA reports that underwriters fully exercised their option to purchase an additional 1,263,750 ADSs in the compa
8-K — Impact 6/10
EDAP TMS S.A. (FOCL) entered into an underwriting agreement for a public offering of 8,425,000 ADSs at $4.75 per ADS, wi
8-K — Impact 6/10
Aug 14, 2026 Insider
Schulz Fran bought 10,000 shares
Director @ $4.75 ($47.5K)
Aug 14, 2026 Insider
WILLSEY LANCE bought 50,000 shares
Director @ $4.75 ($237.5K)
Aug 14, 2026 Insider
Aug 13, 2026 SEC Shah Sanket bought 5,000 shares
General Counsel & Corp Sec @ $4.75 ($23.8K)
FocalTherics (FOCL) reported strong Q2 2026 HIFU continuing operations revenue of $13.2M (+39% YoY), with 13 Focal One s
8-K — Impact 6/10
FocalTherics (FOCL) priced an underwritten public offering of 8,425,000 ADSs at $4.75 per ADS, expecting gross proceeds
Impact 6/10
Analyst ratings buy % +9.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
73% rate it Buy or better · 11 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 25, 2026 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Jun 2, 2026 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Apr 9, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | 43% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 6 | 3 | 0 | 0 | 73% | |
| Aug 1, 2026 | 2 | 6 | 3 | 0 | 0 | 73% | |
| Jul 1, 2026 | 2 | 5 | 3 | 0 | 0 | 70% | |
| Jun 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| May 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| Apr 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| Mar 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| Feb 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% |
Price targets
Where 5 covering analysts think FOCL trades over the next 12 months.
$8.80 +109.5% upside Strong Buy
Current$4.20 Low$4.00 Median$10.00 High$15.00 5 analysts
$4.00$15.00
Analyst rating Buy· 1.8/5 as of Oct 3, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
5 SEC filing reports analyzed · 1 bullish, 2 bearish, 1 mixed, 1 neutral · avg impact 5.8/10.Plus 1 press releases.
BEARISH8-K6/10
EDAP TMS SA reports that underwriters fully exercised their option to purchase an additional 1,263,7
Aug 19, 2026
BEARISH8-K6/10
EDAP TMS S.A. (FOCL) entered into an underwriting agreement for a public offering of 8,425,000 ADSs
Aug 14, 2026
MIXED8-K6/10
FocalTherics (FOCL) reported strong Q2 2026 HIFU continuing operations revenue of $13.2M (+39% YoY),
Aug 13, 2026
BULLISH8-K7/10
FocalTherics (formerly EDAP TMS) reported preliminary Q2 2026 HIFU revenue of $12.7M-$13.2M (+34-39%
Aug 11, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 1, 2026
other
FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026 Company to Present and Host 1x1 Investor Meeting
Aug 26, 2026
earnings_calendar
FOCL Q2 2026 Earnings Scheduled — 2026-08-26
Aug 13, 2026
earnings
FocalTherics™ Reports Second Quarter 2026 Financial Results
39% Revenue Increase and 47% Growth in U.S. Procedures 39% Revenue Increase and 47% Growth in U.S. Procedures
Aug 13, 2026
ftd
FTD: FOCL — 296,938 shares ($1.4M) failed to deliver
Settlement: 20260813, Price: $4.75, FTD Value: $1,410,455.5, EDAP TMS S.A. SPONS ADR
Aug 12, 2026
offering
FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares
FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.26 | $-0.26–$-0.26 | -73.4% | -20.9% | — | $0.0B | 1 |
| Next Q | $-0.27 | $-0.27–$-0.27 | -5.9% | -50.0% | — | $0.0B | 1 |
| Current FY | $-1.04 | $-1.04–$-1.04 | -30.1% | -27.6% | — | $0.1B | 1 |
| Next FY | $-0.67 | $-0.79–$-0.51 | 35.9% | -10.2% | — | $0.1B | 3 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.260 | — |
| 7d ago | $-0.260 | — |
| 30d ago | $-0.215 | -0.045 |
| 60d ago | $-0.210 | -0.050 |
| 90d ago | $-0.225 | -0.035 |
Institutional ownership
Which big funds own FOCL (from quarterly 13F filings) and who is adding or trimming.
21 institutional holders with $25.8M total value (4,974,456 shares) as of 2026-Q2. Top holders: MORGAN, SUSQUEHANNA, JANE. Net buying activity: 3 institutions added/increased vs 1 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| MORGAN STANLEY | 3,336,872 | $17.3M | 67.1% | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 392,200 | $2.0M | 7.9% | — |
| JANE STREET GROUP, LLC | 271,500 | $1.4M | 5.5% | — |
| CITADEL ADVISORS LLC | 169,200 | $876.5K | 3.4% | — |
| US BANCORP \DE\ | 122,500 | $634.5K | 2.5% | — |
| UBS Group AG | 118,395 | $613.3K | 2.4% | TRIM -30.2% |
| Cetera Investment Advisers | 74,012 | $383.4K | 1.5% | ADD +33.9% |
| JANE STREET GROUP, LLC | 71,800 | $371.9K | 1.4% | — |
| COMMONWEALTH EQUITY SERVICES, LLC | 69,160 | $358.3K | 1.4% | — |
| CITADEL ADVISORS LLC | 66,183 | $342.8K | 1.3% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| UBS Group AG | TRIM | 169,630 | 118,395 | -30.2% | $613.3K |
| Schonfeld Strategic Advisors LLC | ADD | 25,861 | 41,730 | +61.4% | $216.2K |
| WELLS FARGO & COMPANY/MN | DOUBLED | 3,500 | 9,424 | +169.3% | $48.8K |
| RHUMBLINE ADVISERS | ADD | 3,042 | 4,432 | +45.7% | $23.0K |
| Schonfeld Strategic Advisors LLC | NEAR_EXIT | 138,580 | 25,861 | -81.3% | $96.2K |
| GROUP ONE TRADING LLC | ADD | 851 | 1,610 | +89.2% | $5.3K |
| UBS Group AG | ADD | 178,449 | 238,220 | +33.5% | $545.5K |
| OSAIC HOLDINGS, INC. | DOUBLED | 1,000 | 43,500 | +4250.0% | $99.6K |
| UBS Group AG | DOUBLED | 38,459 | 178,449 | +364.0% | $294.4K |
| BNP PARIBAS FINANCIAL MARKETS | TRIM | 40,505 | 26,105 | -35.6% | $43.1K |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
4 insiders, 4 transactions. Net $408.5K — $408.5K bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Schulz Fran | Director | BUY | 10,000 | $4.75 | $47.5K |
| Aug 14, 2026 | WILLSEY LANCE | Director | BUY | 50,000 | $4.75 | $237.5K |
| Aug 14, 2026 | Shah Sanket | General Counsel & Corp Sec | BUY | 5,000 | $4.75 | $23.8K |
| Aug 14, 2026 | Rhodes Ryan | Chief Executive Officer | BUY | 21,000 | $4.75 | $99.8K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for FOCL.
Shares short
245,665
Settlement Sep 15, 2026
Change vs prior
-13.7%
Semi-monthly cycle
Days to cover
3.1
At avg daily volume
Of shares outstanding
≈0.7%
Estimate — not % of float
All FOCL filing & press-release reports (6)
- 8-K reportAug 19, 2026
- 8-K reportAug 14, 2026
- 8-K reportAug 13, 2026
- PRESS-RELEASE reportAug 12, 2026
- 8-K reportAug 11, 2026
- PRESS-RELEASE reportJul 30, 2026